Ogawa et al. found that the enhanced expression of p53 could induce apoptosis and autophagy in cancer-associated fibroblasts (CAFs), impede the peritoneal metastasis of GC, and improve the sensitivity of chemotherapy (Ogawa et al., 2022). Here, TP53 is linked to gastric cancer.